Latest News for: pdac

Edit

Phanes Therapeutics to Present Phase 1/2 Study Results of Spevatamig (PT886) in Combination with Chemotherapy in Frontline (1L) Treatment of Metastatic PDAC at ASCO GI 2026

PR Newswire 09 Dec 2025
SAN DIEGO, Dec. 9, 2025 /PRNewswire/ -- Phanes Therapeutics, Inc ... This marks the first public release of Phanes' clinical trial data from their ongoing U.S. multi-center study with spevatamig. Details of the presentation are below.. Title ... Abstract #. 709 ... .
Edit

2025 PDAC (Volt Carbon Technologies Inc)

Public Technologies 02 Dec 2025
). Suite 117 - Arcuri Business Centre 70 Country Hills Landing NW Calgary, AB T3K 2L2. P. (519-763-1197). Email. info@voltcarbontech.com Web. https.//www.voltcarbontech.com ... November 19, 2025, Calgary, AB, Canada - Volt Carbon Technologies Inc ... VCT) (OTCQB.
Edit

TAP Sleep Care Secures Full Medicare Portfolio Coverage: Nylon flexTAP® Receives PDAC Approval

Enid News & Eagle 01 Dec 2025
... Data Analysis, and Coding (PDAC) approval for .
Edit

MHRA Approves BetaGlue Therapeutics’ Clinical Trial Application for YntraDose™ in unresectable Locally Advanced Pancreatic Cancer (uLA-PDAC)

Pharmiweb 13 Nov 2025
LA-PDAC remains a significant health concern and an unmet medical need. The incidence of LA-PDAC has increased by 1.0% per year since the late 1990s, and it is projected to become the second-leading cause of cancer-related mortality by 2030.
Edit

Blue Lagoon Resources Inc. (VAN:BLLG) Wins PDAC 2026 Sustainability Award - Ellis Martin Report with Rana Vig (Blue Lagoon Resources Inc)

Public Technologies 06 Nov 2025
). The text version of this document is not available ... Disclaimer ... (noodl. 127579577) .
Edit

Blue Lagoon Resources Selected for PDAC's 2026 Sustainability Award (Blue Lagoon Resources Inc)

Public Technologies 05 Nov 2025
). The text version of this document is not available ... Disclaimer ... (noodl. 127532482) .
Edit

PDAC announces 2026 Awards recipients

Resource World 05 Nov 2025
The Prospectors & Developers Association of Canada (PDAC) is pleased to announce the recipients of the 2026 PDAC Awards, celebrating the people and partnerships driving discovery, development, and sustainable growth in the mineral industry.
Edit

Cantargia Presents Data at an AACR Conference Strengthening IL1RAP as a Targetable Hallmark in PDAC

Pharmiweb 01 Oct 2025
High IL1RAP protein expression on tumor cells is linked to poor survival in PDAC patients treated with chemotherapy, while this patient group has the longest survival when treated with nadunolimab in combination with chemotherapy.
Edit

Cantargia presents data at an AACR Conference strengthening IL1RAP as a targetable hallmark in PDAC (Cantargia AB)

Public Technologies 01 Oct 2025
2025-10-01 00.00.00 CEST Cantargia AB - Investor News Cantargia presents data at an AACR Conference strengthening IL1RAP as a targetable hallmark in PDAC ... These data pave the way for nadunolimab in different treatment regimens targeting PDAC.
  • 1

Article Search

tools
×
×
×
×